BRCA1 and cancer: Overall, our results suggest that both BRCA1 epimutation, as well as germline mutation carriers acquire methylation changes that are not present in cancer free women and heathy women five years before cancer diagnosis, and those changes affect processes, which disruption has been shown to occur during breast cancer pathology.